Search research articles
Contact Us
Filters
Showing results (1-10 of 192) with videos related to
Page
of 20
Sort By:
Journal of the National Cancer Institute
|
September 2, 2016
Response
Wen-Chi Pan, Hwai-I Yang
Clinical Liver Disease
|
April 18, 2019
Predicting clinical outcome in a patient with chronic hepatitis B virus infection
Hwai-I Yang, Pei-Jer Chen
Alimentary Pharmacology & Therapeutics
|
February 18, 2021
Editorial: incorporating liver stiffness to risk scores for HCC in patients with chronic hepatitis B treated with oral antivirals: ready to use or not?
Hwai-I Yang, Yao-Chun Hsu
Journal of Viral Hepatitis
|
May 5, 2019
Discrepant range of sPD-1 in different studies of chronic hepatitis B. A letter in response to Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
Wen-Juei Jeng, Hwai-I Yang
Journal of Gastroenterology and Hepatology
|
February 18, 2011
Natural history of chronic hepatitis B REVEALed
Chien-Jen Chen, Hwai-I Yang
Epidemiology (Cambridge, Mass.)
|
March 16, 2017
Causal Mediation Analysis of Survival Outcome with Multiple Mediators
Yen-Tsung Huang, Hwai-I Yang
JAMA Oncology
|
April 26, 2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Yuanyuan Kong, Jidong Jia, Hwai-I Yang
Gut
|
February 6, 2014
Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation
Jessica Liu, Hwai-I Yang, Chien-Jen Chen
American Journal of Epidemiology
|
October 31, 2013
Author reply: To PMID 23355498
Rohit Loomba, Hwai-I Yang, Chein-Jen Chen
Genetic Epidemiology
|
March 31, 2018
A multiple mediator analysis approach to quantify the effects of the ADH1B and ALDH2 genes on hepatocellular carcinoma risk
Stephannie Shih, Yen-Tsung Huang, Hwai-I Yang
Page
of 20
Search research articles
Search
Showing results (1-10 of 192) with videos related to
Sort By:
Page
of 20
Journal of the National Cancer Institute
|
September 2, 2016
Response
Wen-Chi Pan, Hwai-I Yang
Clinical Liver Disease
|
April 18, 2019
Predicting clinical outcome in a patient with chronic hepatitis B virus infection
Hwai-I Yang, Pei-Jer Chen
Alimentary Pharmacology & Therapeutics
|
February 18, 2021
Editorial: incorporating liver stiffness to risk scores for HCC in patients with chronic hepatitis B treated with oral antivirals: ready to use or not?
Hwai-I Yang, Yao-Chun Hsu
Journal of Viral Hepatitis
|
May 5, 2019
Discrepant range of sPD-1 in different studies of chronic hepatitis B. A letter in response to Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
Wen-Juei Jeng, Hwai-I Yang
Journal of Gastroenterology and Hepatology
|
February 18, 2011
Natural history of chronic hepatitis B REVEALed
Chien-Jen Chen, Hwai-I Yang
Epidemiology (Cambridge, Mass.)
|
March 16, 2017
Causal Mediation Analysis of Survival Outcome with Multiple Mediators
Yen-Tsung Huang, Hwai-I Yang
JAMA Oncology
|
April 26, 2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Yuanyuan Kong, Jidong Jia, Hwai-I Yang
Gut
|
February 6, 2014
Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation
Jessica Liu, Hwai-I Yang, Chien-Jen Chen
American Journal of Epidemiology
|
October 31, 2013
Author reply: To PMID 23355498
Rohit Loomba, Hwai-I Yang, Chein-Jen Chen
Genetic Epidemiology
|
March 31, 2018
A multiple mediator analysis approach to quantify the effects of the ADH1B and ALDH2 genes on hepatocellular carcinoma risk
Stephannie Shih, Yen-Tsung Huang, Hwai-I Yang
Page
of 20